Differential effect of modified Medical Research Council Dyspnea, COPD Assessment Test, and Clinical COPD Questionnaire for symptoms evaluation within the new GOLD staging and mortality in COPD

Chest

Volumn 148, Issue 1, 2015, Pages 159-168

  Casanova, Ciro ^a   Marin, Jose M ^b   Martinez Gonzalez, Cristina ^c   De Lucas Ramos, Pilar ^d   Mir Viladrich, Isabel ^e   Cosio, Borja ^f,g   Peces Barba, German ^g,h   Solanes García, Ingrid ⁱ   Agüero, Ramón ^j   Feu Collado, Nuria ^k   Calle Rubio, Miryam ^l   Alfageme, Inmaculada ^m   De Diego Damia, Alfredo ⁿ   Irigaray, Rosa ^o   Marín, Margarita ^p   Balcells, Eva ^g,q   Llunell, Antonia ^r   Galdiz, Juan Bautista ^s   Golpe, Rafael ^t   Lacarcel, Celia ^u   Cabrera, Carlos ^v   Marin, Alicia ^w   Soriano, Joan B ^x   Lopez Campos, Jose Luis ^g,y   Soler Cataluña, Juan José ^z   De Torres, Juan P ^aa   more..

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^e HOSPITAL SON LLÀTZER   (Spain)

^f HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^g INSTITUTO DE SALUD CARLOS III   (Spain)

^h HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

ⁱ HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

^j HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^k UNIVERSITY OF CÓRDOBA   (Spain)

^l HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^m HOSPITAL UNIVERSITARIO DE VALME   (Spain)

ⁿ HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^o HOSPITAL DE MANACOR   (Spain)

^p HOSPITAL GENERAL DE CASTELLÓN   (Spain)

^q HOSPITAL DEL MAR   (Spain)

^r HOSPITAL DE TERRASSA   (Spain)

^s HOSPITAL DE CRUCES   (Spain)

^t Allergy Service   (Spain)

^u Hosp Univ Ciudad de Jaén   (Spain)

^v HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^w HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^x HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

^y HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^z HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^aa UNIVERSITY CLINIC OF NAVARRA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT TOOL; CLINICAL COPD QUESTIONNAIRE; COMORBIDITY; COPD ASSESSMENT TEST; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; CLINICAL TRIAL; COHORT ANALYSIS; COMPLICATION; HEALTH STATUS INDICATOR; MIDDLE AGED; MULTICENTER STUDY; PREDICTIVE VALUE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SPAIN; SYMPTOM ASSESSMENT;

AGED; COHORT STUDIES; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUESTIONNAIRES; ROC CURVE; SPAIN; SYMPTOM ASSESSMENT;

EID: 84937553877     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.14-2449     Document Type: Article

References (25)

1. Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347-365.
2. Jones PW, Brusselle G, Dal Negro RW, et al . Properties of the COPD assessment test in a cross-sectional European study. Eur Respir J. 2011;38(1):29-35.
3. Nishimura K, Izumi T, Tsukino M, Oga T. Dyspnea is a better predictor of 5-year survival than airway obstruction in patients with COPD. Chest. 2002;121(5):1434-1440.
4. Almagro P, Martinez-Camblor P, Soriano JB, et al. Finding the best thresholds of FEV1 and dyspnea to predict 5-year survival in COPD patients: the COCOMICS study. Plos One. 2014;9(2):e89866.
5. López-Campos JL, Peces-Barba G, Soler-Cataluña JJ, et al; En Nombre del Grupo de Estudio CHAIN . Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization. Arch Bronconeumol. 2012;48(12): 453-459.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373-383.
7. Agustí A, Soler JJ, Molina J, et al. Is the CAT questionnaire sensitive to changes in health status in patients with severe COPD exacerbations? COPD. 2012;9(5):492-498.
8. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
9. American Thoracic Society . Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis. 1991;144(5):1202-1218.
10. Macintyre N, Crapo RO, Viegi G, et al. Standardisation of the single-breath determination of carbon monoxide uptake in the lung. Eur Respir J. 2005; 26(4):720-735.
11. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories . ATS statement: guide lines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111-117.
12. Mahler DA, Wells CK. Evaluation of clinical methods for rating dyspnea. Chest. 1988;93(3):580-586.
13. Celli BR, Cote CG, Marin JM, et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease . N Engl J Med. 2004;350(10):1005-1012.
14. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648-654.
15. van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13.
16. Jones PW, Tabberer M, Chen WH. Creating scenarios of the impact of COPD and their relationship to COPD Assessment Test (CAT™) scores. BMC Pulm Med. 2011;11:42.
17. Han MK, Muellerova H, Curran-Everett D, et al . GOLD 2011 disease severity classification in COPDGene: a prospective cohort study . Lancet Respir Med. 2012;1(1):43-50.
18. de Torres JP, Marin JM, Martinez-Gonzalez C, et al COPD History Assessment in Spain (CHAIN) Cohort. Clinical application of the COPD assessment test: longitudinal data from the COPD History Assessment in Spain (CHAIN) cohort. Chest. 2014;146(1):111-122.
19. Casanova C, Marin JM, Martinez-Gonzalez C, et al; COPD History Assessment In SpaiN (CHAIN) Cohort. New GOLD classification: longitudinal data on group assignment. Respir Res. 2014;15:3.
20. Domingo-Salvany A, Lamarca R, Ferrer M, et al. Health-related quality of life and mortality in male patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(5):680-685.
21. Oga T, Nishimura K, Tsukino M, Sato S, Hajiro T. Analysis of the factor related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167(4):544-549.
22. Marin JM, Cote CG, Diaz O, et al. Prognostic assessment in COPD: health related quality of life and the BODE index. Respir Med. 2011;105(6):916-921.
23. Lange P, Marott JL, Vestbo J, et al. Prediction of the clinical course of chronic obstructive pulmonary disease, using the new GOLD classifi cation: a study of the general population. Am J Respir Crit Care Med. 2012;186(10):975-981
24. Agusti A, Hurd S, Jones P, et al . FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. Eur Respir J. 2013;42(5):1391-1401 .
25. Pinto LM, Gupta N, Tan W, et al; CanCOLD Study Group. Derivation of normative data for the COPD assessment test (CAT). Respir Res. 2014;15:68.